Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
Avanos Medical, Inc. Announces Third Quarter 2025 Results
07:00am, Wednesday, 05'th Nov 2025
Delivered double-digit growth in Specialty Nutrition Systems segment Closed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segment Raising and n
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
10:31am, Monday, 27'th Oct 2025
ALPHARETTA, Ga. , Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on
WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business
08:00am, Thursday, 23'rd Oct 2025
ANN ARBOR, Mich. , Oct. 23, 2025 /PRNewswire/ -- WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avan
Janney Montgomery Scott LLC Sells 5,237 Shares of Avanos Medical, Inc. $AVNS
03:44am, Wednesday, 22'nd Oct 2025
Janney Montgomery Scott LLC reduced its holdings in Avanos Medical, Inc. (NYSE: AVNS) by 26.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commi
AVANOS MEDICAL (AVNS) to Release Quarterly Earnings on Wednesday
03:00am, Wednesday, 22'nd Oct 2025
AVANOS MEDICAL (NYSE: AVNS - Get Free Report) will likely be announcing its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect the company to announce earnings of $0.1
Avanos Medical: After Transformation Efforts, I Expect Inorganic Growth To Push The Price Up
03:28am, Sunday, 05'th Oct 2025
Avanos Medical is deeply undervalued, with strong international expansion, aggressive M&A strategy, and a new CFO poised to drive inorganic growth. AVNS operates in high-growth markets, maintains a so
Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio
09:45am, Thursday, 18'th Sep 2025
AVNS acquires Nexus Medical, adding its TKO connector to expand critical care offerings and drive immediate revenue and earnings growth.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
01:36pm, Wednesday, 10'th Sep 2025
AVNS's solid Q2 performance, strong product demand, and strategic transformation support growth amid tariff and FX headwinds.
The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice
10:00am, Friday, 29'th Aug 2025
Avanos Medical, Inc. appears deeply undervalued after years of restructuring, with a potential stabilization in sales and earnings projected for 2025. Recent tariff impacts and lowered guidance seem f
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down
02:10pm, Wednesday, 06'th Aug 2025
AVNS shares dip 12% as Q2 earnings miss estimates, margins shrink, and tariff pressures weigh on profitability.
Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript
01:26pm, Tuesday, 05'th Aug 2025
Avanos Medical, Inc. (NYSE:AVNS ) Q2 2025 Earnings Conference Call August 5, 2025 9:00 AM ET Company Participants David C. Pacitti - Chief Executive Officer Jason M.
Avanos Medical (AVNS) Q2 Revenue Up 2%
11:58am, Tuesday, 05'th Aug 2025
Avanos Medical (AVNS) Q2 Revenue Up 2%
Avanos Medical (AVNS) Misses Q2 Earnings Estimates
08:45am, Tuesday, 05'th Aug 2025
Avanos Medical (AVNS) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.34 per share a year ago.
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of Scott Galovan as its new senior vice preside
Avanos Medical, Inc. Announces Second Quarter 2025 Results
06:30am, Tuesday, 05'th Aug 2025
ALPHARETTA, Ga. , Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2025 financial results.
